DK159322C - Analogifremgangsmaade til fremstilling af 4ae-epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller farmaceutisk acceptable syreadditionssalte deraf og 4ae-epi-9-deoxy-9a-aza-9a-homoerythromycin a til anvendelse som udgangsmateriale ved fremgangsmaaden - Google Patents

Analogifremgangsmaade til fremstilling af 4ae-epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller farmaceutisk acceptable syreadditionssalte deraf og 4ae-epi-9-deoxy-9a-aza-9a-homoerythromycin a til anvendelse som udgangsmateriale ved fremgangsmaaden

Info

Publication number
DK159322C
DK159322C DK518683A DK518683A DK159322C DK 159322 C DK159322 C DK 159322C DK 518683 A DK518683 A DK 518683A DK 518683 A DK518683 A DK 518683A DK 159322 C DK159322 C DK 159322C
Authority
DK
Denmark
Prior art keywords
methyl
epi
analogum
doso
prepar
Prior art date
Application number
DK518683A
Other languages
English (en)
Other versions
DK159322B (da
DK518683D0 (da
DK518683A (da
Inventor
Gene Michael Bright
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK518683D0 publication Critical patent/DK518683D0/da
Publication of DK518683A publication Critical patent/DK518683A/da
Publication of DK159322B publication Critical patent/DK159322B/da
Application granted granted Critical
Publication of DK159322C publication Critical patent/DK159322C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
DK518683A 1982-11-15 1983-11-14 Analogifremgangsmaade til fremstilling af 4ae-epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller farmaceutisk acceptable syreadditionssalte deraf og 4ae-epi-9-deoxy-9a-aza-9a-homoerythromycin a til anvendelse som udgangsmateriale ved fremgangsmaaden DK159322C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44197982A 1982-11-15 1982-11-15
US44197982 1982-11-15

Publications (4)

Publication Number Publication Date
DK518683D0 DK518683D0 (da) 1983-11-14
DK518683A DK518683A (da) 1984-05-16
DK159322B DK159322B (da) 1990-10-01
DK159322C true DK159322C (da) 1991-02-25

Family

ID=23755068

Family Applications (1)

Application Number Title Priority Date Filing Date
DK518683A DK159322C (da) 1982-11-15 1983-11-14 Analogifremgangsmaade til fremstilling af 4ae-epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller farmaceutisk acceptable syreadditionssalte deraf og 4ae-epi-9-deoxy-9a-aza-9a-homoerythromycin a til anvendelse som udgangsmateriale ved fremgangsmaaden

Country Status (26)

Country Link
EP (1) EP0109253B1 (da)
JP (1) JPS59104398A (da)
KR (1) KR850000968B1 (da)
AT (1) ATE30237T1 (da)
AU (1) AU544790B2 (da)
CA (1) CA1239639A (da)
CS (1) CS241069B2 (da)
DD (1) DD216017A5 (da)
DE (1) DE3374065D1 (da)
DK (1) DK159322C (da)
EG (1) EG16641A (da)
ES (2) ES8600327A1 (da)
FI (1) FI72980C (da)
GR (1) GR79425B (da)
GT (1) GT198304062A (da)
HU (1) HU193886B (da)
IE (1) IE56234B1 (da)
IL (1) IL70228A (da)
NO (1) NO160262C (da)
NZ (1) NZ206259A (da)
PH (2) PH19293A (da)
PL (2) PL143281B1 (da)
PT (1) PT77645B (da)
SU (1) SU1272996A3 (da)
YU (2) YU43198B (da)
ZA (1) ZA838460B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE38519T1 (de) * 1983-09-06 1988-11-15 Pfizer Azahomoerythromycin-b-derivate und zwischenprodukte.
US4465674A (en) * 1983-09-06 1984-08-14 Pfizer Inc. Azahomoerythromycin D derivative and intermediates therefor
RU2066324C1 (ru) * 1987-07-09 1996-09-10 Пфайзер Инк. Кристаллический дигидрат азитромицина и способ его получения
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
SI8911498B (sl) * 1989-07-26 1998-10-31 Pliva Postopek za pripravo derivatov tilozina
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
CA2064985A1 (en) * 1991-04-05 1992-10-06 Robert R. Wilkening 8a-aza-8a-homoertyhromycin cyclic lactams
CA2065222A1 (en) * 1991-04-09 1992-10-10 Robert R. Wilkening Process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers
EP0508795A1 (en) * 1991-04-10 1992-10-14 Merck & Co. Inc. 8a-aza-8a-homoerythromycin cyclic iminoethers
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
CA2065218A1 (en) * 1991-04-11 1992-10-12 Robert R. Wilkening Process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives
CA2068951A1 (en) * 1991-05-20 1992-11-21 Robert R. Wilkening Process for the preparation of 8a-aza-8a-homoerythromycin cyclic lactams
EP0549040A1 (en) * 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
DE69524214T3 (de) * 1994-05-06 2008-05-15 Pfizer Inc. Azithromycin enthaltende arzneiverabreichungsformen mit gesteuerter wirkstoffabgabe
PT102006B (pt) * 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
EP1206476B1 (en) * 1999-08-24 2006-01-04 Abbott Laboratories 9a-azalides with antibacterial activity
EP1246831B1 (en) * 2000-01-04 2008-03-05 Teva Pharmaceutical Industries Ltd. Preparation method of azithromycin dihydrate
CA2419873A1 (en) 2000-08-23 2002-02-28 Wockhardt Limited Process for preparation of anhydrous azithromycin
US6852262B2 (en) 2002-05-09 2005-02-08 The Gillette Company Insert molding razor cartridges
BRPI0416534A (pt) 2003-12-04 2007-01-09 Pfizer Prod Inc composições multiparticuladas com estabilidade melhorada
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
CA2547774A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Method for making pharmaceutical multiparticulates

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI7910768A8 (en) * 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
JPS5788193A (en) * 1980-11-21 1982-06-01 Pliva Pharm & Chem Works 11-aza-10-deoxo-10-dihydroerythromycin a, derivatives and manufacture
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents

Also Published As

Publication number Publication date
DD216017A5 (de) 1984-11-28
ES543638A0 (es) 1986-01-16
YU197285A (en) 1986-08-31
IE56234B1 (en) 1991-05-22
PH21560A (en) 1987-12-11
YU43198B (en) 1989-04-30
ZA838460B (en) 1985-06-26
IL70228A0 (en) 1984-02-29
PH19293A (en) 1986-03-04
EP0109253A2 (en) 1984-05-23
NZ206259A (en) 1986-08-08
ES527249A0 (es) 1985-10-01
CS241069B2 (en) 1986-03-13
DK159322B (da) 1990-10-01
NO160262B (no) 1988-12-19
DK518683D0 (da) 1983-11-14
HU193886B (en) 1987-12-28
FI834163A (fi) 1984-05-16
SU1272996A3 (ru) 1986-11-23
PL142601B1 (en) 1987-11-30
PL250350A1 (en) 1985-04-24
GT198304062A (es) 1985-05-04
JPS59104398A (ja) 1984-06-16
DK518683A (da) 1984-05-16
AU2130983A (en) 1984-05-24
NO160262C (no) 1989-03-29
HUT35273A (en) 1985-06-28
IL70228A (en) 1987-03-31
YU224383A (en) 1986-04-30
FI72980B (fi) 1987-04-30
NO834146L (no) 1984-05-16
GR79425B (da) 1984-10-22
FI834163A0 (fi) 1983-11-14
ES8604257A1 (es) 1986-01-16
EP0109253A3 (en) 1984-09-12
ES8600327A1 (es) 1985-10-01
KR840006673A (ko) 1984-12-01
YU43425B (en) 1989-06-30
IE832652L (en) 1984-05-15
EP0109253B1 (en) 1987-10-14
EG16641A (en) 1990-08-30
KR850000968B1 (ko) 1985-07-02
CS845583A2 (en) 1985-07-16
JPH0140038B2 (da) 1989-08-24
PL244557A1 (en) 1985-03-26
DE3374065D1 (en) 1987-11-19
PL143281B1 (en) 1988-01-30
ATE30237T1 (de) 1987-10-15
AU544790B2 (en) 1985-06-13
FI72980C (fi) 1987-08-10
CA1239639A (en) 1988-07-26
PT77645A (en) 1983-12-01
PT77645B (en) 1986-05-12

Similar Documents

Publication Publication Date Title
DK159322C (da) Analogifremgangsmaade til fremstilling af 4ae-epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller farmaceutisk acceptable syreadditionssalte deraf og 4ae-epi-9-deoxy-9a-aza-9a-homoerythromycin a til anvendelse som udgangsmateriale ved fremgangsmaaden
EP0136830A3 (en) Azahomoerythromycin d derivative and intermediates therefor
DK159450C (da) 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin b og farmaceutisk acceptable syreadditionssalte deraf samt 9-deoxo-9a-aza-9a-homoerythromycin b til anvendelse som mellemprodukt ved fremstilling deraf
FI821288A0 (fi) Fenetanolaminderivat, deras framstaellning och deras terapeutiska anvaendning
ES515015A0 (es) "procedimiento para la preparacion de 3-0-desmetil-2"-n-formimidoilistamicina b".
FI813476L (fi) Basiskt substituerade 5-fenyltetrazoler foerfarande foer deras framstaellning och deras anvaendning som laekemedel
SE8206128D0 (sv) Farmaceutisk komposition for behandling av njurstenar framkallade genom infektion
DK573981A (da) Fremgangsmaade til fremstilling af cis-c-3",c4"-carbonatderivater af o-demethyl-oleandomycin og mellemprodukter herfor
SE7801527L (sv) 2,4-diklorfenyl-triazolyl-etan-oner(oler) till anvendning som fungicider och sett att framstella foreningarna

Legal Events

Date Code Title Description
PBP Patent lapsed